Dr. Simuni graduated with her medical degree from Leningrad Medical School and completed an internship in medicine in Leningrad, Russia. She subsequently completed an internship in internal medicine at Albert Einstein Medical Center and a neurology residency and a clinical neurophysiology fellowship at Temple University in Philadelphia, Pennsylvania. She then pursued a movement disorders fellowship at the University of Pennsylvania, where she served on the clinical faculty of the Department of Neurology for three years and held the position of Medical Co-Director of the Parkinson’s disease (PD) and Movement Disorders surgical program prior to her current positions.

Dr. Simuni joined the faculty of the Northwestern University Feinberg School of Medicine in 2000 to build and lead a multidisciplinary movement disorders center that is recognized by the Parkinson’s Foundation, Huntington Disease Society of America and Wilson’s Foundation as a Center of Excellence and serves as a training model in the region. She is the lead investigator of a number of clinical trials on experimental pharmacology, non-motor manifestations, and pharmacological management of PD. She serves on a number of Steering Committees for the PD national clinical trials, several committees of the Parkinson Study Group and the Parkinson Foundation. She is the Site PI and serve on the Steering Committee for the largest PD biomarker initiative funded by the MJFF (PPMI study). Dr. Simuni is the site PI for the Network for Excellence in Neuroscience Clinical Trials (NEXT) Northwestern Clinical Site (U10). She has more than a hundred publications in peer-reviewed scientific journals and book chapters and she has lectured nationally and internationally on PD and other movement disorders. In addition to her research career, Dr Simuni is highly committed to education of the next generation of physician s and has served as the Northwestern Neurology residency program director from 2001 to 2014.

Dr. Simuni is an active member of the American Academy of Neurology, American Neurological Association, the Movement Disorders Society as well as the Parkinson’s Study Group.